Skip to main content

Advertisement

Log in

The 18th Annual Scientific Conference of the Society on NeuroImmune Pharmacology

  • GUEST COMMENTARY
  • Published:
Journal of Neuroimmune Pharmacology Aims and scope Submit manuscript

Abstract

The 18th Annual Conference of the Society on Neuroimmune Pharmacology (SNIP) will be held at the Hawaii Prince Hotel Waikiki in Honolulu, Hawaii from April 25–28, 2012. The conference will focus on defining the role of substances of abuse in modulating neuroimmune processes and determining the physiological and behavioral consequences of such alterations in infectious diseases, with HIV infection as the prime model. This focus will include basic and clinical neuroscience, neuroAIDS, and other neurodegenerative processes, as well as the behavioral sciences. The conference also will address the relationship between substances of abuse and HIV/AIDS, particularly with regard to etiology, genetics, epidemiology, prevention, treatment, health services, and therapeutic developments. A major goal of the conference and SNIP is to promote the professional development of young investigators. Thus, four events will be dedicated to young investigators. In addition, the Asian American Pacific Islander (AAPI) workgroup of the NIDA Special Population Office has collaborated with the Society to sponsor Early Career Investigators who will present their research. An exciting and comprehensive program has been assembled that brings together scientists and practitioners from around the world providing a platform for them to share their research and discuss the translational clinical and epidemiological relevance of this research to the community at large.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Acknowledgments

Preparation of this manuscript was supported, in part, by the National Institutes of Health grants, DA016149 (SLC), DA005832 (GAC), and DA029532 (GAC). We thank the Carol Swarts Emerging Neuroscience Laboratory, Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, the Society on NeuroImmune Pharmacology, and Springer for their support in publishing this abstract book. We also thank Drs. Sylvia Kiertscher and Michael Roth for their time and effort in organizing the abstracts that were submitted.

Conflict of Interest

The authors have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sulie L. Chang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chang, S.L., Cabral, G.A. The 18th Annual Scientific Conference of the Society on NeuroImmune Pharmacology. J Neuroimmune Pharmacol 7 (Suppl 1), 1–4 (2012). https://doi.org/10.1007/s11481-012-9348-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11481-012-9348-1

Keywords

Navigation